Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1-Rearranged NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I Study
J. Clin. Oncol 2024 Jun 01;[EPub Ahead of Print], W Li, A Xiong, N Yang, H Fan, Q Yu, Y Zhao, Y Wang, X Meng, J Wu, Z Wang, Y Liu, X Wang, X Qin, K Lu, W Zhuang, Y Ren, X Zhang, B Yan, CM Lovly, C ZhouFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.